Role of ctDNA in MRD

preview_player
Показать описание
Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of next-generation sequencing and circulating tumor DNA (ctDNA) in the treatment and management of breast cancer, such as disease monitoring and minimal residual disease (MRD). This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.
  1. VJOncology
  2. Speaker: Andrew A. Davis
  3. Institution: Washington University School of Medicine
  4. Event: SABCS 2021
  5. Format: Interview
  6. Subject: Breast Cancer
Рекомендации по теме
Role of ctDNA 0:01:23

Role of ctDNA in MRD

The role of 0:03:32

The role of ctDNA in lung cancer screening

The emerging role 0:02:53

The emerging role of MRD in colorectal cancer decision making

The emerging role 0:00:45

The emerging role of ctDNA in cancer diagnostics

Potential Use of 0:04:01

Potential Use of ctDNA and MRD in CRC

Farshid Dayyani, MD 0:00:53

Farshid Dayyani, MD | Importance of ctDNA and MRD Testing

Adham Jurdi, MD 0:02:59

Adham Jurdi, MD | Importance of ctDNA and MRD Testing

John Marshall, MD 0:01:05

John Marshall, MD | Importance of ctDNA and MRD Testing

Pashtoon Kasi, MD, 0:01:12

Pashtoon Kasi, MD, MS | Importance of ctDNA and MRD Testing

ctDNA and MRD 0:58:52

ctDNA and MRD | 2023 Best of GI Cancer Conference

Axel Grothey, MD 0:02:37

Axel Grothey, MD | Importance of ctDNA and MRD Testing

ctDNA and MRD: 0:46:53

ctDNA and MRD: Who, When, and Then What? | 2022 Evolution Conference

Significance of ctDNA 0:03:14

Significance of ctDNA in assessing MRD and novel strategies in gastrointestinal cancers

ctDNA and MRD—How, 0:02:03

ctDNA and MRD—How, When, and on Who Do We Use It | Kristen Ciombor, MD | ESMO22 Pennsylvania

ctDNA MRD detection 0:07:53

ctDNA MRD detection from plasma and urine in colorectal cancer

The utility of 0:03:16

The utility of ctDNA in colorectal cancer management

Evolving applications of 0:03:43

Evolving applications of ctDNA in lung cancer: MRD, early detection, and molecular profiling

ctDNA as an 0:03:30

ctDNA as an MRD biomarker for NSCLC

Arturo Loaiza-Bonilla, MD 0:01:03

Arturo Loaiza-Bonilla, MD | Why is ctDNA and MRD Testing Important?

Applications of ctDNA 0:02:06

Applications of ctDNA in oncology

Axel Grothey, MD, 0:01:28

Axel Grothey, MD, considers the role of circulating tumor DNA (ctDNA)

How can ctDNA 0:05:13

How can ctDNA assess MRD and profile tumor types in lung cancer?

ctDNA MRD detection 0:01:07

ctDNA MRD detection in patients with NSCLC

Gregory Botta, MD, 0:00:51

Gregory Botta, MD, PhD | Why is ctDNA and MRD Testing Important?